Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

Marco Ruella, David M. Barrett, Saad S. Kenderian, Olga Shestova, Ted J. Hofmann, John Scholler, Simon F. Lacey, Jan J. Melenhorst, Farzana Nazimuddin, Jessica Perazzelli, David A. Christian, Christopher A. Hunter, David L. Porter, Carl H. June, Stephan A. Grupp, Saar Gill

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells'. Together they form a unique fingerprint.